PALISADE CAPITAL MANAGEMENT, LP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 137 filers reported holding IMMUNOGEN INC in Q1 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2017$80,000
-14.9%
12,500
+1.6%
0.00%0.0%
Q3 2017$94,000
+261.5%
12,300
-2.4%
0.00%
+200.0%
Q4 2016$26,00012,6000.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders